New Delhi, Mar 2 (PTI) Homegrown FMCG maker Dabur on Monday introduced an funding of ₹60 crore to accumulate a minority stake in D2C firm RAS Magnificence.
Its funding platform, Dabur Ventures has signed a definitive settlement to accumulate minority stake in new-age luxurious skincare D2C firm, mentioned a joint assertion.
Based by three girls, RAS Magnificence is a Raipur-based digital first, quick rising “Farm-to-Face” luxurious skincare model with a presence within the pure magnificence phase. Its key merchandise, which embrace face elixirs, serums, and moisturisers, are infused with important oils and nature-derived actives.
Dabur India Govt Director – Group Head Company Technique Abhinav Dhall, mentioned: “RAS gives a definite skincare worth proposition on the confluence of nature, science and luxurious. We imagine that the premium magnificence phase will witness sturdy progress within the coming decade, and RAS Magnificence is well-positioned to seize the rising alternative.”
RAS Magnificence has a CAGR of round 75 per cent in three years with an ARR of roughly ₹100 crore.
That is additionally the primary funding from Dabur Ventures, which was launched in October 2025 with an intent to accumulate a stake in high-potential, new-age D2C companies.
RAS Magnificence co-founder and CEO Shubhika Jain mentioned: “This funding will allow us to speed up our omnichannel presence, deepen our R&D capabilities, and spend money on model and workforce constructing, all in pursuit of our longer-term aim of constructing RAS a number one title in Indian luxurious skincare, at house and globally, whereas staying true to our core values.”
Dabur Ventures has been arrange with a capital allocation of ₹500 crore to spend money on ventures working in Private Care, Well being Care, Wellness Meals, Drinks, and Ayurveda.